Image Features | Malignant Lesions (n = 245) | Benign Lesions (n = 173) | Total | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
HCC (n = 204) | OM (n = 41) | DN/RN (n = 22) | FNH (n = 28) | Hemangiom (n = 60) | Biliary adenoma (n = 4) | AML (n = 8) | IPT (n = 32) | Lipoma (n = 7) | NEN (n = 12) | ||
Gray-scale echogenicity | |||||||||||
Hyperechoic | 20 | 3 | 1 | 2 | 57 | 0 | 5 | 2 | 7 | 9 | 106 |
Hypoechoic | 184 | 38 | 21 | 26 | 3 | 4 | 3 | 30 | 0 | 3 | 312 |
Arterial phase | |||||||||||
Hyperenhancemenr | |||||||||||
Homogeneous | 184 | 6 | 18 | 28 | 31 | 2 | 7 | 29 | 3 | 11 | 319 |
Inhomogenous | 2 | 2 | 0 | 0 | 14 | 0 | 0 | 0 | 0 | 1 | 19 |
Rim | 5 | 20 | 0 | 0 | 2 | 0 | 1 | 1 | 0 | 0 | 29 |
Peripheral nodular | 7 | 13 | 0 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 33 |
Isoenhancement | 3 | 0 | 4 | 0 | 0 | 2 | 0 | 2 | 4 | 0 | 15 |
Hypoenhancement | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
Late phase enhancements | |||||||||||
Isoenhancement | 28 | 0 | 13 | 19 | 35 | 4 | 3 | 18 | 3 | 5 | 128 |
Hypoenhancement | 172 | 41 | 4 | 0 | 7 | 0 | 2 | 12 | 0 | 2 | 240 |
Hyperenhancement | 4 | 0 | 5 | 9 | 18 | 0 | 3 | 2 | 4 | 5 | 50 |
Washout | |||||||||||
No washout | 32 | 0 | 18 | 28 | 53 | 4 | 6 | 20 | 7 | 10 | 178 |
delayed and moderate | 158 | 2 | 4 | 0 | 7 | 0 | 2 | 12 | 0 | 2 | 187 |
< 60 s | 9 | 22 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 32 |
Marked, ≤120 s | 2 | 18 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20 |